Clinical Trial Update: Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC [Phase 3]

View source ↗

Summary

Open-label Phase 3 trial comparing ATV/RTV+3TC versus ATV/RTV+TDF/FTC in treatment-naïve HIV patients, followed by ATV/RTV+3TC; study terminated with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• ATV/RTV+3TC (atazanavir/ritonavir + lamivudine)
• ATV/RTV+TDF/FTC (atazanavir/ritonavir + tenofovir disoproxil fumarate/emtricitabine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV | Phase 3 | Status: TERMINATED | Results posted: 2021-08-06